Company profile: Natural Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of science- and technology-driven health offerings focused on the Omega-3 segment; a Norwegian market leader dedicated to raising awareness among Central European consumers of the health benefits of diets rich in fish and marine fatty acids.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Natural Pharmaceuticals
Aptus Clinical
HQ: United Kingdom
Website
- Description: Provider of specialist clinical contract research services, offering Catalyst Oncology, a clinical research organization focusing on oncology supporting biotech companies in developing cancer therapies, and Catalyst Flex, multi-therapeutic functional service provider solutions including clinical operations, data management, biostatistics, programming, safety, and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aptus Clinical company profile →
ZenBio
HQ: United States
Website
- Description: Provider of human cell-based research products and contract research services, including preadipocytes and adipocytes for drug screening and development; cell-based assay development and custom consultations; individualized cell-based or biochemical screening programs; cell characterization and molecular biology services; and ready-to-use visceral preadipocyte and adipocyte media.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ZenBio company profile →
ProtaGene
HQ: Germany
Website
- Description: Provider of analytic services for biopharmaceutical, cell, and gene therapy development, delivering complete protein and gene analytics and product testing. Offerings include product characterization and attribute analysis, method development, GMP testing, QC lot release and stability methods, candidate evaluation and optimization, IND selection, and commercial-stage comparability testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProtaGene company profile →
Cognivia
HQ: Belgium
Website
- Description: Provider of analytical tools and services to optimize and speed clinical development of novel medicines, including Placebell to reduce data variability by addressing placebo response and patient heterogeneity; Compl-AI to predict non-adherence and dropout risks to aid patient engagement; and an Expert Analysis Service to detect and explain clinical site variability and help adjust data for clearer study results.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cognivia company profile →
Doppel Farmaceutici
HQ: Italy
Website
- Description: Provider of contract development and manufacturing for pharmaceutical and nutritional products, covering formulation, development, manufacturing, packaging, marketing and post-marketing controls. Delivers R&D for formulation/analytical methods, clinical trial batches and regulatory consultancy. Manufactures solids, semi-solids, liquids, sprays, sterile products, injectables, medical devices, soft gelatin capsules, highly potent drugs, and food/effervescent supplements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Doppel Farmaceutici company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Natural Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Natural Pharmaceuticals
2.2 - Growth funds investing in similar companies to Natural Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Natural Pharmaceuticals
4.2 - Public trading comparable groups for Natural Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →